DD vs SRTAW · P/E 127, rev $3.50B vs rev $248.7M
Dupont De Nemours Inc (DD) versus Strata Critical Medical, Inc. (SRTAW) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ.
Latest reported DD revenue for 2026-06-30 was $3.50B. Net income was $304.0M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported SRTAW revenue for 2024-12-31 was $248.7M. Net income was -$27.3M. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. SRTAW currently screens at market cap $0.
DD currently screens at market cap $19.61B and trailing P/E 127.4. SRTAW currently screens at market cap $0.
Not investment advice. Open the DD and SRTAW stock pages for the full models.
Not investment advice.